Steve Kanes

[Steve Kanes @sjkanes]

@TamarGurMDPhD Congratulations!!

[Sage Therapeutics @SageBiotech]

$SAGE announces strategic collaboration with Japan’s Shionogi & Co., Ltd., to develop and commercialize SAGE-217 for MDD and other indications in Japan, Taiwan, and South Korea. https://t.co/GzSzZtnivE

[Jessica O'Leary @biochemjessie]

We are pleased to collaborate with Shionogi, a company that shares our excitement at the opportunity to work together to accelerate development and broaden geographic access to a potentially paradigm-shifting treatment for depression https://t.co/bxDl5hSwHE

[Phil Bridges @PhilBridges]

Dr. Samantha Meltzer-Brody, who runs the UNC Center for Women’s Mood Disorders talks to Huffington Post about about the development of what may be the first drug for Postpartum Depression. https://t.co/kgPqdtRTPz #PostPartumDepression #PPD #UNC #MoodDisorders #UNC #brexanolone

[Steve Kanes @sjkanes]

#postpartumdepression is a common complication of pregnancy and delivery. Screening is critical for patients to get the attention and care they need #PPD https://t.co/YRLmE8W3wg

[PT @PVT12345123]

Time to make perinatal & #postpartumdepression screening mandatory https://t.co/wSLx5dZSLT

[Sage Therapeutics @SageBiotech]

Today $Sage announced that our two Phase 3 trials in PPD met primary endpoints in moderate and severe #PPD trials. https://t.co/1MLZxG7UqY

[S Meltzer-Brody @smeltzerb]

https://t.co/aVA3Ct5nfd

[Mental Health Foundation @mentalhealth]

Half of new mums' mental health problems don't get picked up. Support @NCTcharity's #HiddenHalf campaign: https://t.co/suBJzYuraG

[Steve Kanes @sjkanes]

@scienmag Outstanding!

[S Meltzer-Brody @smeltzerb]

Clinical phenotypes of perinatal depression & time of symptom onset: analysis of data from international consortium https://t.co/FZTtlXnFkj

[PPD Documentary @boughbreaksdoc]

Great news!

"Partnership between AHN, Alexis Joy D'Achille Foundation Leads to Unique Center Offering a Wide... https://t.co/V09FT7c0Wy

[Steve Kanes @sjkanes]

Essential tremor is the most common movement disorder. This fact sheet has the details #essentialtremor https://t.co/L7tAYOqye0

[George Nomikos @gnomikos1]

https://t.co/MLPtb57T04

[Steve Kanes @sjkanes]

https://t.co/ate44A15O1

[Steve Kanes @sjkanes]

This it what progress looks like in fighting the #stigma of #PPD. A new mother centered clinic in NYC. https://t.co/fgH2MvxL9Q

[S Meltzer-Brody @smeltzerb]

Delighted to participate today in Maternal Mental Health advocacy day representing North Carolina! #MMHDC2017 @JZahlaway2 @MMHcoalition

[Steve Kanes @sjkanes]

Awareness and understanding can save a life. #mentalhealthawareness #maternalMHmatters #PPD https://t.co/jU1w7CXoPG

[American Foundation for Suicide Prevention @afspnational]

May is #MentalHealthAwareness month.

[Steve Kanes @sjkanes]

Look for our #PPDsilencesucks disease education initiative on local buses and trains in the Boston area this month! #PPDsilencesucks. #PPD

[Steve Kanes @sjkanes]

The stigma attached to PPD is a critical barrier to treatment. A first step in breaking this barrier is awareness. #PPD #PPDsilencesucks https://t.co/yqg3ET0MOe

[Sage Therapeutics @SageBiotech]

We’re live at #ACOG17! Visit us at Booth #1623 to learn how you can help break the silence of postpartum depression. #PPDsilencesucks

[Steve Kanes @sjkanes]

We are excited to share our progress with SAGE-217 in #depression #MDD https://t.co/T2OOCm48XK

[Sage Therapeutics @SageBiotech]

Sage achieves pos activity/tolerability in open-label trial of SAGE-217 in major depressive disorder planning Ph2 placebo controlled trial